NewGenIvf Group Ltd (NASDAQ:NIVF)
| Market Cap | $33.02K-100.0% |
| Revenue (ttm) | $1.93B+64360.5% |
| Net Income | -$8.03B-1519402.0% |
| EPS | -$6537.82-677341.3% |
| Shares Out | 1.23M |
| PE Ratio | n/a |
| Forward PE | 0.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 270,767,852 |
| Open | $0.03 |
| Previous Close | $0.04 |
| Day's Range | $0.02 - $0.03 |
| 52-Week Range | $0.02 - $7257.60 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 3, 2027 |
About NIVF
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.
Next catalysts
- Mar 3, 2027Earnings report
$NIVF stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NIVF holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NIVF's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NIVF Estimated quarterly lobbying spending
Source: U.S. Senate LDA
NIVF Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New NIVF patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NIVF from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from NIVF’s recent data — informational, not investment advice
What’s Behind the Score
News check: Successful completion of $2.5M capital raise and business update indicate operational progress and investor confidence in company trajectory.
